SCHEMBL31672360

SCHEMBL31672360

C=CC(=O)N1CC(N2CCN(C(=O)CNc3cc(CC(F)(F)F)c(Cl)cc3O)CC2)C1

nearest known ligand 0.77

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KRAS P01116 18/20 0.77
▸ EGLN1 Q9GZT9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16100135 1.00 KRAS (0.77) KRASEGLN1
SCHEMBL31672331 0.89 KRAS (0.83) KRAS
SCHEMBL16100289 0.89 KRAS (0.83) KRAS
SCHEMBL16122668 0.89 KRAS (0.60) KRAS
SCHEMBL31672334 0.88 KRAS (1.00) KRASEGLN1
SCHEMBL16103039 0.88 KRAS (1.00) KRASEGLN1
SCHEMBL20260100 0.85 KRAS (0.55) KRAS
SCHEMBL16102399 0.85 KRAS (0.83) KRAS
SCHEMBL16117843 0.84 KRAS (0.85) KRASEGLN1
SCHEMBL31672380 0.84 KRAS (0.85) KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE50527-E1 Covalent inhibitors of KRAS G12C ARAXES PHARMA LLC (US) 2025-08-12 — — US disclosed
Send feedback